Αποτελέσματα Αναζήτησης
ADULTS. Initially, 20 mg PO; up to 80 mg PO daily in the evening. Usual range, 5–80 mg/day. Maximum dose, 80 mg/day. Adjust at 4-wk intervals. Familial hypercholesterolemia: 40 mg/day PO in the evening, or 80 mg/day divided into doses of 20 mg, 20 mg, and 40 mg in the evening.
- Spironolactone Nursing Considerations & Management
Drug Name Generic Name : spironolactone Brand Name:...
- Valproic Acid Nursing Considerations & Management
Nursing considerations. CLINICAL ALERT! Confusion has...
- Erythromycin Nursing Considerations & Management
Systemic administration . Culture site of infection before...
- Butorphanol Tartrate Nursing Considerations & Management
Drug Name Generic Name : butorphanol tartrate Brand Name:...
- Spironolactone Nursing Considerations & Management
4 Μαΐ 2024 · Learn about the different classes of antihyperlipidemic drugs, their indications, pharmacokinetics, adverse effects, and nursing considerations. Simvastatin is a HMG-CoA reductase inhibitor that lowers cholesterol and triglyceride levels.
5 Ιουν 2023 · This activity outlines the indications, mechanism of action, methods of administration, significant adverse effects, contraindications, and monitoring, of simvastatin, so providers can direct patient therapy in treating hyperlipidemia as part of the interprofessional team.
Statins Nursing Interventions: Rationales; Check the patient’s blood test results, particularly the LDL and HDL levels. Assess the patient for signs and symptoms of hypercholesterolemia. To confirm the indication for administering statins. Check the patient’s allergy status.
26 Αυγ 2024 · Do not take simvastatin if you are pregnant. Stop taking this medication and tell your doctor right away if you become pregnant. Use effective birth control to avoid pregnancy while you are taking this medicine. Simvastatin may pass into breast milk and could harm a nursing baby. Do not breast-feed while you are taking this medicine.
18 Μαρ 2004 · Nursing considerations - Carry out lipid profile. - Assess cholesterol at six weeks. - Perform liver function tests in first year of treatment. - In the case of rhabdomyolysis with increased muscle tenderness and creatine phosphokinase, therapy should be discontinued. - Renal tests for patients with impaired renal function.
Simvastatin tablets are an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce the risk of total mortality by reducing CHD deaths and reduce the risk of non-fatal myocardial infarction, stroke, and the need for revascularization procedures in patients at high risk of coronary events.
